U-Chart Analysis:SEIKAGAKU CORPORATION:4548

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index SEIKAGAKU CORPORATION Go to web site 4548 Medicals 東証プライム March 1, 2000 1989.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

SEIKAGAKU CORPORATION Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

SEIKAGAKU CORPORATION Balance Sheet 2024年3月期 SEIKAGAKU CORPORATION Balance Sheet 2023年3月期 SEIKAGAKU CORPORATION Balance Sheet 2022年3月期 SEIKAGAKU CORPORATION Balance Sheet 2021年3月期 SEIKAGAKU CORPORATION Balance Sheet 2020年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Cash and Cash Equivalents 15,439 23,451 21,518 15,192 13,100
Other Current AssetsHelp 26,107 23,259 27,107 28,366 27,300
Tangible Fixed AssetsHelp 15,219 11,325 10,021 8,302 7,662
Intangible Fixed AssetHelp 1,093 1,137 834 818 766
Investments and OthersHelp 21,830 14,359 13,671 15,705 17,825
Total AssetsHelp 81,795 75,625 75,244 69,915 68,746
Total Current LiabilitiesHelp 9,452 8,357 8,846 6,254 8,910
Total Long-term LiabilitiesHelp 61 52 58 57 69
Shareholder's EquityHelp 72,282 67,216 66,340 63,604 59,767
Total LiabilitiesHelp 81,795 75,625 75,244 69,915 68,746

SEIKAGAKU CORPORATION Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

SEIKAGAKU CORPORATION Profit and Loss Account 2024年3月期 SEIKAGAKU CORPORATION Profit and Loss Account 2023年3月期 SEIKAGAKU CORPORATION Profit and Loss Account 2022年3月期 SEIKAGAKU CORPORATION Profit and Loss Account 2021年3月期 SEIKAGAKU CORPORATION Profit and Loss Account 2020年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Amount of Sales 36,213 33,456 34,851 27,662 28,642
Total Sales 36,213 33,456 34,851 27,662 28,642
Cost of SalesHelp 19,336 15,432 14,323 12,112 12,513
Other Costs and RevenueHelp 14,691 15,787 16,794 11,289 26,968
Total CostsHelp 34,027 31,219 31,117 23,401 39,481
Net RevenueHelp 16,877 18,024 20,528 15,550 16,129
Earnings Before TaxHelp 1,691 3,069 5,395 3,024 -9,543
Net IncomeHelp 2,186 2,237 3,734 4,261 -10,839
Net Income 2,186 2,237 3,734 4,261 -10,839

SEIKAGAKU CORPORATION Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

SEIKAGAKU CORPORATION Cash Flow Statement 2024年3月期 SEIKAGAKU CORPORATION Cash Flow Statement 2023年3月期 SEIKAGAKU CORPORATION Cash Flow Statement 2022年3月期 SEIKAGAKU CORPORATION Cash Flow Statement 2021年3月期 SEIKAGAKU CORPORATION Cash Flow Statement 2020年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Operating Cash Flow(OFC)Help 514 1,574 8,191 1,258 8,670
Investing Cash Flow(ICF)Help -7,209 3,365 870 1,023 623
Financing Cash FlowHelp -1,461 -3,244 -2,151 -1,507 -1,603
Exchange Difference of Cash and Cash EquivalentsHelp 1,060 735 689 1 -11
Net Increase and Decrease in Cash and Cash Equivalentsn -7,096 2,430 7,599 775 7,679

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

SEIKAGAKU CORPORATION

Company where related level is highHelp

TAISHO PHARMACEUTICAL CO.,LTD.
Shionogi & Co.,Ltd.
NANO MRNA Co., Ltd.
D.Western Therapeutics Institute, Inc.
ROHTO PHARMACEUTICAL CO.,LTD.
MediciNova,Inc
BIOFERMIN PHARMACEUTICAL CO.,LTD.
Solasia Pharma K.K.
Renascience Inc.
STELLA PHARMA CORPORATION